Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders
[...]the refractory cases in our cohort were treated with anti–TNF-α agents, and it successfully induced the remission. [...]our study demonstrated that HA20 showed unexpected variation in clinical manifestations. [...]he was identified as having a heterozygous c.2088+5G>C mutation in TNFAIP3 (Fi...
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 141; no. 4; pp. 1485 - 1488.e11 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.04.2018
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [...]the refractory cases in our cohort were treated with anti–TNF-α agents, and it successfully induced the remission. [...]our study demonstrated that HA20 showed unexpected variation in clinical manifestations. [...]he was identified as having a heterozygous c.2088+5G>C mutation in TNFAIP3 (Fig E2). At the age of 1 year, colonoscopy revealed the ulceration of rectum and colon. [...]he was diagnosed as having nonspecific inflammatory bowel disease and treated with mesalazine. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Correspondence-2 content type line 14 ObjectType-Letter to the Editor-1 ObjectType-Article-2 ObjectType-Correspondence-1 content type line 23 |
ISSN: | 0091-6749 1097-6825 1097-6825 |
DOI: | 10.1016/j.jaci.2017.10.039 |